LW
BIO icon

Libra Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History

Libra Wealth’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-445
Closed -$213K – 53
2023
Q1 		$213K Buy
+445
New +$208K 0.12% 47
2022
Q3 		– Sell
-445
Closed -$220K – 47
2022
Q2 		$220K Buy
+445
New +$232K 0.16% 37
2022
Q1 		– Sell
-500
Closed -$378K – 35
2021
Q4 		$378K Buy
+500
New +$374K 0.24% 19

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Libra Wealth's BIO Position: Q2 2023 in Review

Libra Wealth sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 445 shares — an estimated $213K sold.

Libra Wealth first reported a position in BIO in Q4 2021 and held it in 3 quarters. The position peaked at $378K in Q4 2021. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • Libra Wealth reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • Libra Wealth sold 445 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $213K.
  • Libra Wealth first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 3 quarters.
  • Libra Wealth's Bio-Rad Laboratories Class A position peaked at $378K in Q4 2021.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Libra Wealth's 13F filing for Q2 2023, filed 10 Aug 2023.